日本ケミファの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/11/10 | 1,672 | 1,686 | 1,672 | 1,686 | +14 | +0.8% | 10,300 |
| 2022/11/09 | 1,665 | 1,674 | 1,662 | 1,672 | +7 | +0.4% | 2,900 |
| 2022/11/08 | 1,650 | 1,674 | 1,649 | 1,665 | +20 | +1.2% | 7,900 |
| 2022/11/07 | 1,675 | 1,675 | 1,642 | 1,645 | -17 | -1% | 9,200 |
| 2022/11/04 | 1,701 | 1,701 | 1,662 | 1,662 | -41 | -2.4% | 11,000 |
| 2022/11/02 | 1,684 | 1,703 | 1,684 | 1,703 | +12 | +0.7% | 6,600 |
| 2022/11/01 | 1,714 | 1,714 | 1,677 | 1,691 | -23 | -1.3% | 13,200 |
| 2022/10/31 | 1,700 | 1,721 | 1,680 | 1,714 | +35 | +2.1% | 12,300 |
| 2022/10/28 | 1,709 | 1,730 | 1,679 | 1,679 | -40 | -2.3% | 35,200 |
| 2022/10/27 | 1,742 | 1,742 | 1,713 | 1,719 | -18 | -1% | 4,800 |
| 2022/10/26 | 1,707 | 1,738 | 1,707 | 1,737 | +39 | +2.3% | 7,000 |
| 2022/10/25 | 1,706 | 1,706 | 1,694 | 1,698 | +3 | +0.2% | 4,900 |
| 2022/10/24 | 1,702 | 1,707 | 1,695 | 1,695 | -7 | -0.4% | 7,800 |
| 2022/10/21 | 1,710 | 1,710 | 1,702 | 1,702 | -8 | -0.5% | 3,100 |
| 2022/10/20 | 1,722 | 1,722 | 1,701 | 1,710 | -14 | -0.8% | 6,700 |
| 2022/10/19 | 1,716 | 1,724 | 1,713 | 1,724 | +6 | +0.3% | 1,400 |
| 2022/10/18 | 1,727 | 1,727 | 1,706 | 1,718 | +2 | +0.1% | 5,600 |
| 2022/10/17 | 1,702 | 1,727 | 1,702 | 1,716 | -10 | -0.6% | 11,000 |
| 2022/10/14 | 1,735 | 1,744 | 1,725 | 1,726 | -1 | -0.1% | 6,300 |
| 2022/10/13 | 1,736 | 1,745 | 1,726 | 1,727 | -20 | -1.1% | 6,400 |
| 2022/10/12 | 1,767 | 1,767 | 1,736 | 1,747 | +18 | +1% | 3,300 |
| 2022/10/11 | 1,753 | 1,757 | 1,729 | 1,729 | -24 | -1.4% | 13,600 |
| 2022/10/07 | 1,755 | 1,776 | 1,751 | 1,753 | -13 | -0.7% | 11,200 |
| 2022/10/06 | 1,755 | 1,766 | 1,755 | 1,766 | +4 | +0.2% | 4,400 |
| 2022/10/05 | 1,770 | 1,775 | 1,761 | 1,762 | -3 | -0.2% | 4,300 |
| 2022/10/04 | 1,761 | 1,777 | 1,760 | 1,765 | +10 | +0.6% | 8,300 |
| 2022/10/03 | 1,761 | 1,765 | 1,755 | 1,755 | -16 | -0.9% | 3,500 |
| 2022/09/30 | 1,781 | 1,790 | 1,759 | 1,771 | -10 | -0.6% | 5,400 |
| 2022/09/29 | 1,765 | 1,785 | 1,765 | 1,781 | +18 | +1% | 4,500 |
| 2022/09/28 | 1,777 | 1,791 | 1,756 | 1,763 | -14 | -0.8% | 11,800 |
| 2022/09/27 | 1,771 | 1,790 | 1,771 | 1,777 | +6 | +0.3% | 2,700 |
| 2022/09/26 | 1,818 | 1,818 | 1,770 | 1,771 | -30 | -1.7% | 10,900 |
| 2022/09/22 | 1,818 | 1,818 | 1,799 | 1,801 | -12 | -0.7% | 6,900 |
| 2022/09/21 | 1,830 | 1,832 | 1,800 | 1,813 | -16 | -0.9% | 7,200 |
| 2022/09/20 | 1,867 | 1,867 | 1,827 | 1,829 | -26 | -1.4% | 11,400 |
| 2022/09/16 | 1,867 | 1,872 | 1,855 | 1,855 | -12 | -0.6% | 3,400 |
| 2022/09/15 | 1,880 | 1,894 | 1,867 | 1,867 | -15 | -0.8% | 5,200 |
| 2022/09/14 | 1,882 | 1,899 | 1,882 | 1,882 | -18 | -0.9% | 4,400 |
| 2022/09/13 | 1,887 | 1,911 | 1,887 | 1,900 | +10 | +0.5% | 6,100 |
| 2022/09/12 | 1,890 | 1,917 | 1,880 | 1,890 | +1 | +0.1% | 4,700 |
| 2022/09/09 | 1,882 | 1,891 | 1,876 | 1,889 | +2 | +0.1% | 5,600 |
| 2022/09/08 | 1,884 | 1,900 | 1,878 | 1,887 | +2 | +0.1% | 6,500 |
| 2022/09/07 | 1,899 | 1,905 | 1,877 | 1,885 | -14 | -0.7% | 6,400 |
| 2022/09/06 | 1,901 | 1,915 | 1,899 | 1,899 | -3 | -0.2% | 7,800 |
| 2022/09/05 | 1,899 | 1,916 | 1,899 | 1,902 | -8 | -0.4% | 3,700 |
| 2022/09/02 | 1,918 | 1,920 | 1,910 | 1,910 | -11 | -0.6% | 4,600 |
| 2022/09/01 | 1,922 | 1,935 | 1,921 | 1,921 | -1 | -0.1% | 3,700 |
| 2022/08/31 | 1,936 | 1,936 | 1,915 | 1,922 | -25 | -1.3% | 3,400 |
| 2022/08/30 | 1,900 | 1,947 | 1,898 | 1,947 | +46 | +2.4% | 5,500 |
| 2022/08/29 | 1,906 | 1,909 | 1,898 | 1,901 | -20 | -1% | 4,800 |
501～
550
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「日ケミファ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日ケミファ | 151,100円 | +2.5% | - | 3.31% | 90.86倍 | 0.29倍 |
|
中堅後発薬メーカー。長期収載品の主力は痛風薬ウラリット。新薬開発、検査薬事業を中期強化 |
| ティムス | 20,500円 | - | - | 0.00% | - | 2.78倍 |
|
東京農工大発創薬ベンチャー。黒カビ由来の急性期脳梗塞薬候補品を香港拠点ジーシンに導出 |
| ノイルイミューン | 17,300円 | -97.8% | - | 0.00% | - | 1.50倍 |
|
独自技術用いたＣＡＲ－Ｔ細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
| カルナバイオ | 31,000円 | -43.1% | - | 0.00% | - | 1.84倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
| ＶＩＳ | 89,000円 | +87.8% | +265.7% | 0.00% | 53.45倍 | 2.45倍 |
|
ｍＲＮＡ標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
市場注目の銘柄
チャート関連のコラム
